April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Application of Activated Protein C in Reducing Soft Contact Lens Associated Fungal Biofilms
Author Affiliations & Notes
  • Loretta B. Szczotka-Flynn
    Ophthalmology & Visual Sciences,
    Case Western Reserve Univ, Cleveland, Ohio
  • Mauricio Returcico
    Dermatology,
    Case Western Reserve Univ, Cleveland, Ohio
  • Donghai Ho
    Ophthalmology & Visual Sciences,
    Case Western Reserve Univ, Cleveland, Ohio
  • Thomas Steinemann
    Ophthalmology & Visual Sciences,
    Case Western Reserve Univ, Cleveland, Ohio
  • Mahmoud Ghannoum
    Dermatology,
    Case Western Reserve Univ, Cleveland, Ohio
  • Footnotes
    Commercial Relationships  Loretta B. Szczotka-Flynn, Alcon (F), Alcon, Bausch & Lomb, Vistakon (R); Mauricio Returcico, Alcon (F); Donghai Ho, None; Thomas Steinemann, None; Mahmoud Ghannoum, Alcon (F)
  • Footnotes
    Support  Prevent Blindness America
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 6478. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Loretta B. Szczotka-Flynn, Mauricio Returcico, Donghai Ho, Thomas Steinemann, Mahmoud Ghannoum; Application of Activated Protein C in Reducing Soft Contact Lens Associated Fungal Biofilms. Invest. Ophthalmol. Vis. Sci. 2011;52(14):6478.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Fibrin is a key component of biofilms acting as a conditioning layer or matrix during biofilm development. Activated Protein C (APC) is a potent physiologic anticoagulant with profibrinolytic properties. This study assessed the activity of APC against soft contact lens associated fungal biofilms using an in-vitro established soft contact lens fungal biofilm model.

Methods: : Fusarium solani 6914 and Fusarium oxysporum 8996 were incubated with three different types of worn contact lenses (lotrafilcon A, balafilcon A, and etafilcon A) from three different subjects under conditions that facilitate biofilm formation. Both strains were obtained from patients with fungal keratitis. Biofilm was quantified using a tetrazolium XTT [2,3-bis (2-methoxy-4-nitro-5-sulfophenyl) -2H -tetrazolium -5 -carboxanilide] assay. Susceptibilities of the fungal biofilm growth phases to 25 ug/ml of APC solution were assessed under two separate conditions: when the APC solution was added during the adhesion phase of biofilm development or after 48 hours of mature biofilm formation.

Results: : APC was not effective against F. solani biofilm formation when added during the adhesion phase. However, when added after mature biofilm had been formed, APC significantly reduced F. solani biofilm activity by 69%, 72%, and 81% for etafilcon A, lotrafilcon A, and balafilcon A lenses, respectively, compared to phosphate buffered saline-soaked worn-lens controls (p<0.05). F. oxysporum biofilm activity was reduced by 26%, 1%, and 1% on etafilcon A, lotrafilcon A, and balafilcon A lenses, respectively, compared to phosphate buffered saline-soaked worn-lens controls.

Conclusions: : APC has potent antifungal activity against a F. solani soft contact associated biofilm using an XTT-based metabolic activity assay. There is variability in its effect as it was ineffective against F. oxysporum or when added prior to mature biofilm development. Nevertheless, further study is warranted as APC is an agent that may have novel anti-biofilm activity and it has potential to be used in combination with contact lens disinfecting products to reduce contact lens associated biofilms.

Keywords: contact lens • fungal disease 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×